(Q45268161)

English

5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis

scientific article published in October 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

Margie L Clapper

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Monique A Gary

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Renata A Coudry

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Samuel Litwin

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Wen-Chi L Chang

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Karthik Devarajan

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Ronald A Lubet

7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Harry S Cooper

8

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

1 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1341-1347

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Colorectal cancer prevention in ulcerative colitis: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

A randomized trial of aspirin to prevent colorectal adenomas

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20489

21 January 2018

Identifiers

10.1002/IBD.20489

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45268161&oldid=2113660324"